8-k BioLife

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T4xUFv+M7sd0lL4gJG6fdzpBGZ3i4T5Of1aouavKSel6fouPnpSo3zj/CQi0JJHy KztpKwbbRuhBhCn6iXURYg== 0001354488-07-001316.txt : 20070725 0001354488-07-001316.hdr.sgml : 20070725 20070725102951 ACCESSION NUMBER: 0001354488-07-001316 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070724 ITEM INFORMATION: Changes in Registrant.s Certifying Accountant FILED AS OF DATE: 20070725 DATE AS OF CHANGE: 20070725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-18170 FILM NUMBER: 07998294 BUSINESS ADDRESS: STREET 1: SUNY PARK SCIENCE III STREET 2: SUITE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 BUSINESS PHONE: 6077772775 MAIL ADDRESS: STREET 1: SUNYPARK SCIENCE III STREET 2: STE 144 CITY: BINGHAMTON STATE: NY ZIP: 13902-6000 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 8-K 1 form8k072507.htm 8-k BioLife

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

July 24, 2007

Date of report (Date of earliest event reported)


	BIOLIFE SOLUTIONS, INC.
	(Exact name of registrant as specified in charter)

Delaware

0-18710

94-3076866

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)


	11810 North Creek Parkway North, Bothell, WA 98011
	(Address of principal executive offices)


	(425) 401-1400
	(Registrant’s Telephone Number, including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-((b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 4.

CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANTS

(b)

New independent accountants

(i)

On July 24, 2007, the Registrant retained Peterson Sullivan PLLC (“Peterson”) as independent auditors for the Registrant for 2007.

(ii)

The Registrant has not previously consulted with Peterson on the application of accounting principles to a specified transaction, or on the type of audit opinion that might be rendered on the Registrant’s financial statements.

Signatures:

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	BIOLIFE SOLUTIONS, INC.

Date: July 24, 2007	By: /s/ Michael Rice
	Michael Rice
	President and Chief Executive Officer (Principal Executive Officer)

-----END PRIVACY-ENHANCED MESSAGE-----